Developing the future
Developing an upstream cell culture process is hard work. We know that you and your team can spend upwards of ten hours a day in the lab setting up and testing a hypothesis. The aim of this event is to provide you with a basis to decide whether or not a particular innovation is right for your company, prior to you and your team spending countless hours in the lab. We’ll do this by providing a forum where leaders will debate the costs versus benefits of selecting certain cell culture process development innovations.
Animal derived vs ADCF (animal derived component free), adherent vs suspension cells, custom media vs off-the-shelf, benefits of new non-mammalian platforms
- Gene therapy researchers
- Research scientists cell culture
- Principal Scientists cell culture
- Upstream process development engineers, scientists, and managers
- MSAT upstream engineers, scientists, and managers